OBJECTIVE: Physical activity is associated with superior health outcomes in patients with type 2 diabetes (T2D), but most T2D patients do not follow physical activity recommendations. The objective of this study was to assess the feasibility and impact of a novel combined positive psychology-motivational interviewing (PP-MI) intervention to promote physical activity in T2D. METHODS: This controlled clinical trial compared an 8-week, phone-delivered PP-MI intervention to an attention-matched MI-enhanced behavioral counseling condition among 60 participants with T2D and suboptimal moderate to vigorous physical activity (MVPA; <150 min/wk). The primary study outcome was feasibility (proportion of sessions completed) and acceptability (0-10 ease and utility ratings of each session). Secondary outcomes were between-group differences in changes in positive affect (main psychological outcome) and accelerometer-measured physical activity (MVPA and steps per day), using mixed-effects regression models, at 8 and 16 weeks. RESULTS: Ninety-two percent of PP-MI sessions were completed, and mean participant ratings of ease/utility were 8.5 to 8.8/10, surpassing a priori benchmarks for feasibility and acceptability. PP-MI participants had small-medium effect size (ES) difference improvements in positive affect compared with MI (8 weeks: estimated mean difference [EMD] = 3.07 [SE = 1.41], p = .029, ES = 0.44; 16 weeks: EMD = 2.92 [SE = 1.73], p = .092, ES = 0.42). PP-MI participants also had greater improvements in MVPA (8 weeks: EMD = 13.05 min/d [SE = 5.00], p = .009, ES = 1.24; 16 weeks: EMD = 7.96 [SE = 4.53], p = .079, ES = 0.75), with similar improvements in steps per day. CONCLUSIONS: The PP-MI intervention was feasible and well accepted. Next-step efficacy studies can more rigorously explore the intervention's effects on physical activity and clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Registration No. NCT03150199.
OBJECTIVE: Physical activity is associated with superior health outcomes in patients with type 2 diabetes (T2D), but most T2D patients do not follow physical activity recommendations. The objective of this study was to assess the feasibility and impact of a novel combined positive psychology-motivational interviewing (PP-MI) intervention to promote physical activity in T2D. METHODS: This controlled clinical trial compared an 8-week, phone-delivered PP-MI intervention to an attention-matched MI-enhanced behavioral counseling condition among 60 participants with T2D and suboptimal moderate to vigorous physical activity (MVPA; <150 min/wk). The primary study outcome was feasibility (proportion of sessions completed) and acceptability (0-10 ease and utility ratings of each session). Secondary outcomes were between-group differences in changes in positive affect (main psychological outcome) and accelerometer-measured physical activity (MVPA and steps per day), using mixed-effects regression models, at 8 and 16 weeks. RESULTS: Ninety-two percent of PP-MI sessions were completed, and mean participant ratings of ease/utility were 8.5 to 8.8/10, surpassing a priori benchmarks for feasibility and acceptability. PP-MI participants had small-medium effect size (ES) difference improvements in positive affect compared with MI (8 weeks: estimated mean difference [EMD] = 3.07 [SE = 1.41], p = .029, ES = 0.44; 16 weeks: EMD = 2.92 [SE = 1.73], p = .092, ES = 0.42). PP-MI participants also had greater improvements in MVPA (8 weeks: EMD = 13.05 min/d [SE = 5.00], p = .009, ES = 1.24; 16 weeks: EMD = 7.96 [SE = 4.53], p = .079, ES = 0.75), with similar improvements in steps per day. CONCLUSIONS: The PP-MI intervention was feasible and well accepted. Next-step efficacy studies can more rigorously explore the intervention's effects on physical activity and clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Registration No. NCT03150199.
Authors: Christopher M Celano; Melanie E Freedman; Eleanor E Beale; Federico Gomez-Bernal; Jeff C Huffman Journal: J Nerv Ment Dis Date: 2018-10 Impact factor: 2.254
Authors: Jeff C Huffman; Eleanor E Beale; Christopher M Celano; Scott R Beach; Arianna M Belcher; Shannon V Moore; Laura Suarez; Shweta R Motiwala; Parul U Gandhi; Hanna K Gaggin; James L Januzzi Journal: Circ Cardiovasc Qual Outcomes Date: 2015-12-08
Authors: Ronald C Plotnikoff; Magdalena Wilczynska; Kristen E Cohen; Jordan J Smith; David R Lubans Journal: Prev Med Date: 2017-09-05 Impact factor: 4.018
Authors: Paul D O'Halloran; Felicity Blackstock; Nora Shields; Anne Holland; Ross Iles; Mike Kingsley; Julie Bernhardt; Natasha Lannin; Meg E Morris; Nicholas F Taylor Journal: Clin Rehabil Date: 2014-06-18 Impact factor: 3.477
Authors: Barbara J Jefferis; Tessa J Parsons; Claudio Sartini; Sarah Ash; Lucy T Lennon; Olia Papacosta; Richard W Morris; S Goya Wannamethee; I-Min Lee; Peter H Whincup Journal: Br J Sports Med Date: 2018-02-12 Impact factor: 13.800
Authors: Christopher M Celano; Melanie E Freedman; Lauren E Harnedy; Elyse R Park; James L Januzzi; Brian C Healy; Jeff C Huffman Journal: J Psychosom Res Date: 2020-10-29 Impact factor: 3.006
Authors: Hermioni L Amonoo; Areej El-Jawahri; Emma C Deary; Lara N Traeger; Corey S Cutler; Joseph A Antin; Jeff C Huffman; Stephanie J Lee Journal: J Clin Oncol Date: 2022-04-04 Impact factor: 50.717
Authors: Jeff C Huffman; Lauren E Harnedy; Christina N Massey; Alba Carrillo; Emily H Feig; Wei-Jean Chung; Christopher M Celano Journal: Health Psychol Behav Med Date: 2022-03-10
Authors: Rachel A Millstein; Julia Golden; Brian C Healy; Hermioni L Amonoo; Lauren E Harnedy; Alba Carrillo; Christopher M Celano; Jeff C Huffman Journal: Health Psychol Behav Med Date: 2022-08-04